These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7672193)

  • 1. Activation of complement by DMSO and ethanol and its inhibition by soluble complement receptor type 1.
    Laver AJ; Hibbs M; Smith RA
    Biochem Soc Trans; 1995 May; 23(2):167S. PubMed ID: 7672193
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological tests: Anaphylatoxins C3a, C4a, C5a].
    Fujino S; Sakurabayashi I
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():80-3. PubMed ID: 16111194
    [No Abstract]   [Full Text] [Related]  

  • 3. Complement activation by heparin-protamine complexes during cardiopulmonary bypass: effect of C4A null allele.
    Shastri KA; Logue GL; Stern MP; Rehman S; Raza S
    J Thorac Cardiovasc Surg; 1997 Sep; 114(3):482-8. PubMed ID: 9305203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolytic treatment and complement activation.
    Agostoni A; Gardinali M; Frangi D; Cugno M; Cafaro C; Conciato L; Sponzilli C; Salmoirago E
    Ann Ital Med Int; 1994; 9(3):178-9. PubMed ID: 7946896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage.
    Kasuya H; Shimizu T
    J Neurosurg; 1989 Nov; 71(5 Pt 1):741-6. PubMed ID: 2809729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation by propofol and its effect during propofol anaesthesia.
    Ohmizo H; Iwama H; Sugita T
    Anaesth Intensive Care; 1999 Dec; 27(6):623-7. PubMed ID: 10631417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible mechanism for in vitro complement activation in blood and plasma samples: futhan/EDTA controls in vitro complement activation.
    Pfeifer PH; Kawahara MS; Hugli TE
    Clin Chem; 1999 Aug; 45(8 Pt 1):1190-9. PubMed ID: 10430784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma C3a and C4a levels in liver transplant recipients: a longitudinal study.
    Pfeifer PH; Brems JJ; Brunson M; Hugli TE
    Immunopharmacology; 2000 Feb; 46(2):163-74. PubMed ID: 10647874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator.
    Agostoni A; Gardinali M; Frangi D; Cafaro C; Conciato L; Sponzilli C; Salvioni A; Cugno M; Cicardi M
    Circulation; 1994 Dec; 90(6):2666-70. PubMed ID: 7994806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation in systemic sclerosis.
    Wild G; Watkins J; Ward AM; Hughes P; Hume A; Rowell NR
    J Clin Lab Immunol; 1990 Jan; 31(1):39-41. PubMed ID: 1966983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complexes of IgG molecules and C3a and C4a complement components in human serum.
    Nezlin R; Freywald A
    Eur J Immunol; 1992 Jul; 22(7):1955-7. PubMed ID: 1623933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement split products C3a and C4a are early markers of acute lyme disease in tick bite patients in the United States.
    Shoemaker RC; Giclas PC; Crowder C; House D; Glovsky MM
    Int Arch Allergy Immunol; 2008; 146(3):255-61. PubMed ID: 18270493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C4a anaphylatoxin levels as an indicator of disease activity in systemic lupus erythematosus.
    Wild G; Watkins J; Ward AM; Hughes P; Hume A; Rowell NR
    Clin Exp Immunol; 1990 May; 80(2):167-70. PubMed ID: 2357842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complement activation during storage of preserved blood].
    Schleunig M; Schmid-Haslbeck M; Wimmer R; Mempel W
    Beitr Infusionsther; 1990; 26():81-5. PubMed ID: 1703907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement-derived anaphylatoxins in human donor corneas treated with excimer laser.
    Gardner BP; Pleyer U; Mondino BJ; Sumner HL; Frieberg ML; Imperia PS
    Ophthalmic Surg Lasers; 1995; 26(6):568-71. PubMed ID: 8746579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of leukocyte depletion on the formation of anaphylatoxins in stored whole blood.
    Schleuning M; Utz H; Heim M; Mempel W
    Infusionsther Transfusionsmed; 1992 Oct; 19(5):242-4. PubMed ID: 1288768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement split products c3a and c4a in chronic lyme disease.
    Stricker RB; Savely VR; Motanya NC; Giclas PC
    Scand J Immunol; 2009 Jan; 69(1):64-9. PubMed ID: 19140878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of the anaphylatoxins C3a and C4a in patients with IgA nephropathy/Henoch-Schönlein nephritis.
    Abou-Ragheb HH; Williams AJ; Brown CB; Milford-Ward A
    Nephron; 1992; 62(1):22-6. PubMed ID: 1436286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement ligand-receptor interactions that mediate biological responses.
    Fearon DT; Wong WW
    Annu Rev Immunol; 1983; 1():243-71. PubMed ID: 6242465
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of complement 4 genetic polymorphism on complement activation during cardiopulmonary bypass in open heart surgery among children].
    Zhang S; Li Q; Yao S
    Zhonghua Yi Xue Za Zhi; 2001 Aug; 81(15):918-20. PubMed ID: 11702666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.